ArticleCancer immunology research2018

Entinostat Converts Immune-Resistant Breast and Pancreatic Cancers into Checkpoint-Responsive Tumors by Reprogramming Tumor-Infiltrating MDSCs.

Brian J Christmas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.